4HF Biotec started several projects to identify new drug targets in all tumor types. Our research is based on integrative analysis of cancer information and  aims to identify treatments that more specifically target cancer cells and limit side effects.

​

A bioinformatics approach is used to curate and prioritize molecular drivers to reveal new cancer vulnerabilities. In a second phase, 4HF Biotec will develop new small molecule-based and antibodies therapeutics that will be evaluated via its drug discovery programs.